Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014)
Armata Pharmaceuticals' (ARMP) quarterly Exchange Rate Effect came in at -$93000.0 in Q3 2014, down 342.86% year-on-year from $38294.1 in Q3 2013, and down 481.25% quarter-over-quarter from -$16000.0 in Q2 2014.
Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014) Analysis & Trends
Armata Pharmaceuticals has disclosed Exchange Rate Effect across 2 years of filings, most recently posting -$93000.0 for Q3 2014.
- Exchange Rate Effect for Q3 2014 came in at -$93000.0, down 342.86% year-over-year; the trailing twelve-month figure through Sep 2014 was -$96000.0 (changed N/A YoY), and the FY2013 annual result was $41000.0, changed N/A from the prior year.
- Exchange Rate Effect came in at -$93000.0 for Q3 2014 at Armata Pharmaceuticals, down from -$16000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $158000.0 in Q2 2013 to a low of -$113000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -93,000.00 |
| Sep 30, 2014 | -93,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Mar 31, 2013 | -113,000.00 |
| Mar 31, 2013 | -113,000.00 |